Page URL:

Hopes for PCOS cure as scientists reveal cause in mice

21 May 2018
Appeared in BioNews 950

Polycystic ovary syndrome (PCOS) may be due to a hormone imbalance before birth, research has revealed. 

The disease may be triggered before birth by excessive exposure to anti-Mϋllerian hormone (AMH) in the womb, researchers found. They were then able to counter the symptoms of the syndrome in mice. A clinical trial to see if the treatment works in women will begin later this year.

In the study in Nature Medicine, Dr Paolo Giacobini at the French National Institute of Health and Medical Research (Inserm), and his team discovered that pregnant women with PCOS have 30 percent higher levels of AMH than usual. As the disease can be hereditary, the researchers then investigated whether the high levels of hormone could induce the same condition in female offspring.

To do this, scientists injected AMH into pregnant mice and found that their offspring developed symptoms which mirrored those observed in women with PCOS, including infrequent ovulation and delays in becoming pregnant. The authors surmised that the excess hormone resulted in overstimulation of a subset of neurons leading to increased levels of testosterone. 

Using the IVF drug cetrorelix to control hormone levels, the researchers were able to reverse the induced symptoms of PCOS in mice. By the end of the year, the team hopes to trial cetrorelix for women with PCOS.

'It could be an attractive strategy to restore ovulation and eventually increase the pregnancy rate in these women,' said Dr Giacobini.

PCOS is estimated to affect between 8 and 20 percent of women. Symptoms of the condition include high levels of testosterone resulting in excessive hair growth and acne, and irregular periods often leading to difficulties conceiving. Despite being a common disorder, the underlying cause has been poorly understood. 

'It's by far the most common hormonal condition affecting women of reproductive age, but it hasn't received a lot of attention,' Professor Robert Norman of the University of Adelaide in Australia, who was not involved in the study, told New Scientist.

The study presents 'a radical new way of thinking about polycystic ovary syndrome and opens up a whole range of opportunities for further investigation', he concluded.

29 March 2021 - by Tsvetana Stoilova 
Men carrying genetic risk factors for polycystic ovary syndrome (PCOS) are more likely to develop diabetes, obesity and male-pattern baldness...
23 November 2020 - by Bethany Muller 
A new drug that may be able to improve fertility for women with ovulatory problems has been showcased by researchers at Imperial College London...
7 May 2019 - by Jakki Magowan 
A gene that plays a key role in causing polycystic ovary syndrome (PCOS) has been discovered, and could lead to better disease prediction and treatment...
12 February 2018 - by Professor Robin Lovell-Badge 
The problem of fertility preservation for girls and women undergoing cancer treatments has been a subject of research for many decades. The recent study by McLaughlin and colleagues from Professor Evelyn Telfer's lab at the University of Edinburgh, UK, is aimed at finding a solution to this problem, with the claim that they have produced mature human egg cells in the lab for the first time...
5 February 2018 - by Dr Thanos Papathanasiou 
Being a healthy weight, eating a varied diet with plenty of fruit and vegetables, taking regular exercise and cutting alcohol – is all good advice for everyone. But the direct influence on these factors on the fertility of both men and women, highlighted this week by a study suggesting a 'Mediterranean diet' in women can boost IVF success rates is now becoming better understood...
15 January 2018 - by Georgia Everett 
Using fresh embryos in IVF gives the same chance of a live birth as using frozen embryos for ovulatory women, according to two new studies...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.